Evidence map›Paper›PMID 36411279›Full record

Observational studyScientific reports2022

Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score).

Bin Liu, Huimin Du, Jing Zhang, Jie Jiang, Xin Zhang, Faming He, Bailin Niu

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 4 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 4 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Treatment Options for Metallo-Beta-Lactamase-ProducingInternational journal of molecular sciences · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bin Liu *Department of Intensive Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Youyi Road No.1, Yuzhong District, Chongqing, 400016, China.
Huimin Du *Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Jing ZhangDepartment of Intensive Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Youyi Road No.1, Yuzhong District, Chongqing, 400016, China.
Jie JiangDepartment of Intensive Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Youyi Road No.1, Yuzhong District, Chongqing, 400016, China.
Xin ZhangGreater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, Shanghai, 200433, China.
Faming HeDepartment of Intensive Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Youyi Road No.1, Yuzhong District, Chongqing, 400016, China.
Bailin NiuDepartment of Intensive Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Youyi Road No.1, Yuzhong District, Chongqing, 400016, China. nberlin@126.com.
Chongqing Medical University · CNChongqing University · CNFudan University · CN

Funding

Chongqing Medical Scientific Research Project (Joint Project of Chongqing Health Commission and Science and Technology Bureau) 2019MSXM019Chongqing Medical Scientific Research Project (Joint Project of Chongqing Health Commission and Science and Technology Bureau) 2021MSXM033Chongqing Natural Science Foundation Project cstc2020jcyj-msxmX0124COVID-19 Emergency Projects of Chongqing Medical University X1-2611
6 · The paper itself

Abstract

Exploring an effective sepsis screening tool that can be widely implemented is important for improving the prognosis of sepsis worldwide. This study aimed to develop a new simple screening tool for sepsis (LIP scoring system) that includes the peripheral blood lymphocyte count, international normalized ratio, and procalcitonin level. In a single-center, prospective, observational study, 444 acute sepsis inpatients and 444 nonsepsis inpatients were ultimately included based on the Sepsis-3 and exclusion criteria. The differences in the Lym, INR, PCT level and other clinical biomarkers were compared between the two groups. Univariable and multivariable logistic regression analyses and receiver operating characteristic analysis were used to establish a LIP screening tool for sepsis with a combination of biomarkers. The Kappa and McNemar tests were used to evaluate the differences between the LIP screening results (LIP score ≥ 3) and Sepsis-3 criteria (SOFA score ≥ 2). Logistic regression analysis showed that the lymphocyte count, INR, PCT level, platelets, neutrophil/lymphocyte ratio (NLR) and prothrombin time (PT) were independent risk factors for the development of sepsis. The ROC analysis showed that the lymphocyte count, INR, and PCT level had high area under the ROC curve values (AUROC (95% CI): Lym 0.84 (0.810-0.860), INR 0.921 (0.902-0.938), PCT level 0.928 (0.909-0.944)). The LIP tool had satisfactory screening efficacy for sepsis (sensitivity, 92.8%; specificity, 94.1%), and a LIP score equal to or greater than 3 points had good agreement with Sepsis-3 criteria in the diagnosis of sepsis (Kappa = 0862 in the Kappa test and P = 0.512 in the McNemar test). The LIP tool has satisfactory sensitivity and specificity for sepsis screening, and it can be used for rapid screening of patients with sepsis in outpatient and emergency departments or in economically underdeveloped areas with limited resources.

Indexed as

ProcalcitoninSepsisBiomarkersHumansInternational Normalized RatioLymphocyte CountProspective StudiesBiomarkersProcalcitonin

Identifiers

PMID36411279
PMCPMC9678875
OpenAlexW4309668092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.